Getting drugs and devices to the doorstep is only half the battle. When digital connections fail, trials fail. Why the digital last mile needs clinical supply ownership, human-centered design, and tech support with a bedside manner.
- The Site Perspective: Why Ambient AI Is The Missing Link In Clinical Trial Data Integrity
- Why HEOR Keeps Arriving Too Late — And How ClinOps Can Fix It
- Accelerating Clinical Innovation With Open-Source Medical Platforms
- From Supercomputers To The Cloud: How Pharma's R&D Infrastructure Transformation Impacts Clinical Trials
- How To Identify Patient-Centric Risks In The TMF With AI And Automation
- How The TMF Demonstrates Patient Safety And Rights In DCTs
- Begin Your AI-Led Digital Clinical Transformation With A Phased Approach
- How AI Is Rewriting The Future Of TMF And Clinical Quality
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
The Case For Cognitive Assessments In Phase 1 Clinical Trials
Regulators prioritize patient-reported outcomes. Cognitive assessments in Phase 1 trials detect early drug-related cognitive effects, ensuring safety and efficacy. Signant’s CDR System® is a proven tool for this.
-
Automated Trial Monitoring Workflows Make A Lean Team More Efficient
A pharmaceutical therapy developer was looking to automate reports, confirmation letters, and follow-up letters. See what happened when they adopted a cloud-based solution for end-to-end trial management.
-
Tech And Strategies For Reaching Underserved Patient Populations
By leveraging flexible solutions, learn how sponsors can proactively address regulatory mandates while advancing the development of safer and more effective therapies for a broader spectrum of patients.
-
How eCOA Improves Data Quality In Clinical Trials
eCOA solutions enhance data quality in clinical trials by preventing common issues in paper-based COA data, such as missing, ambiguous, or conflicting entries, and ensuring reliable data collection.
-
How Digital Therapeutics Tools Interact To Improve Patient Care
This comprehensive overview illustrates the intersection between prescription digital therapeutics, digital health tools, and decentralized clinical trials in a remote care setting.
-
Revolutionizing Pediatric Clinical Trials With ePRO And eConsent
Digital tools like ePRO and eConsent are essential in addressing pediatric trial challenges such as the diverse participant ages and family involvement, which impact retention and data quality.
-
Empowering Clinical Trial Sponsors With Analytics
Explore data challenges faced by sponsors, the underlying problems driving those challenges, and flexible processes and solutions designed to help overcome them.
-
eTMF Systems Tell Compelling Story Of COVID-19 Vaccines
The rapid development of Covid-19 vaccines may lead more drug developers to increase their speed and agility by adopting electronic Trial Master File (eTMF) systems. In the case of Covid-19 vaccines, discover how eTMF systems tell a dramatic tale.
-
Different Stakeholder Perspectives On Navigating DHT Guidance
In a recent panel, industry leaders discussed the implications of FDA guidance for sponsors and developers implementing DHT as an innovative way to capture multidimensional patient data remotely.
-
Lessons From China And The United States On The Use Of RWE In Regulatory Submissions
Read along as authors share their most significant lessons, offering guidance on how to harness the full potential of RWE to drive innovation and efficiency in drug development.